JP2008526749A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526749A5
JP2008526749A5 JP2007549507A JP2007549507A JP2008526749A5 JP 2008526749 A5 JP2008526749 A5 JP 2008526749A5 JP 2007549507 A JP2007549507 A JP 2007549507A JP 2007549507 A JP2007549507 A JP 2007549507A JP 2008526749 A5 JP2008526749 A5 JP 2008526749A5
Authority
JP
Japan
Prior art keywords
peptide
membrane
pharmaceutical composition
self
biologically compatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007549507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526749A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/046768 external-priority patent/WO2006073889A2/en
Publication of JP2008526749A publication Critical patent/JP2008526749A/ja
Publication of JP2008526749A5 publication Critical patent/JP2008526749A5/ja
Pending legal-status Critical Current

Links

JP2007549507A 2005-01-04 2005-12-29 自己アセンブリするペプチドナノファイバーを用いたpdgfの徐放性の送達 Pending JP2008526749A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64099805P 2005-01-04 2005-01-04
US70231805P 2005-07-26 2005-07-26
PCT/US2005/046768 WO2006073889A2 (en) 2005-01-04 2005-12-29 Sustained delivery of pdgf using self-assembling peptide nanofibers

Publications (2)

Publication Number Publication Date
JP2008526749A JP2008526749A (ja) 2008-07-24
JP2008526749A5 true JP2008526749A5 (cg-RX-API-DMAC7.html) 2009-01-22

Family

ID=36648006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007549507A Pending JP2008526749A (ja) 2005-01-04 2005-12-29 自己アセンブリするペプチドナノファイバーを用いたpdgfの徐放性の送達

Country Status (6)

Country Link
US (1) US7429567B2 (cg-RX-API-DMAC7.html)
EP (1) EP1833504A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008526749A (cg-RX-API-DMAC7.html)
AU (1) AU2005323062A1 (cg-RX-API-DMAC7.html)
CA (1) CA2592292A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006073889A2 (cg-RX-API-DMAC7.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2572964C (en) * 2004-07-06 2018-03-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
KR20100102750A (ko) * 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법
HUE037994T2 (hu) * 2006-04-25 2018-09-28 Massachusetts Inst Technology Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására
CA2655933C (en) * 2006-06-23 2014-09-09 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
EP2066697A2 (en) * 2006-09-26 2009-06-10 Massachusetts Institute of Technology Modified self-assembling peptides
US7696309B2 (en) * 2006-10-23 2010-04-13 The Brigham And Women's Hospital, Inc. Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
US9187517B2 (en) 2006-11-13 2015-11-17 The Brigham And Women's Hospital, Inc. Methods of promoting cardiac repair using growth factors fused to heparin binding sequences
JP5558104B2 (ja) * 2006-12-11 2014-07-23 スリー−ディー マトリックス, インコーポレイテッド 心組織の保護および再生のための組成物および方法
US9415084B2 (en) * 2007-03-14 2016-08-16 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
CN105435211A (zh) 2008-10-06 2016-03-30 三维肽胶株式会社 组织闭塞剂
CN104829714A (zh) 2008-11-03 2015-08-12 阿莱斯亚生物疗法股份有限公司 特异性地阻滞肿瘤抗原的生物活性的抗体
US20110117195A1 (en) * 2009-11-18 2011-05-19 National Cheng Kung University Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers
WO2011072482A1 (en) 2009-12-14 2011-06-23 The University Of Hong Kong Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells
JP5732691B2 (ja) * 2010-01-14 2015-06-10 学校法人同志社 インスリン製剤
WO2011106234A1 (en) 2010-02-25 2011-09-01 Provasculon, Inc. Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
CA2893376A1 (en) 2011-03-31 2012-10-04 Alethia Biotherapeutics Inc. Antibodies against kidney associated antigen 1 and antigen binding fragemnts thereof
JP6145089B2 (ja) 2011-06-07 2017-06-07 メソブラスト インターナショナル エスエイアールエル ストロマ細胞由来因子−1のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法
AU2013209234B2 (en) 2012-01-09 2017-11-09 Adc Therapeutics Sa Method for treating breast cancer
WO2014004467A1 (en) 2012-06-25 2014-01-03 The Brigham And Women's Hospital, Inc. Selective cartilage therapy
US9421245B2 (en) 2012-06-25 2016-08-23 The Brigham And Women's Hospital, Inc. Targeted therapeutics
US9790264B2 (en) 2012-06-25 2017-10-17 The Brigham And Women's Hospital, Inc. Compounds and methods for modulating pharmacokinetics
EP2869903B1 (en) 2012-07-06 2018-11-28 3-D Matrix Ltd. Fill-finish process for peptide solutions
EP2698162A1 (en) 2012-08-15 2014-02-19 Credentis AG Method for producing a composition for treating a tooth lesion
JP6118905B2 (ja) * 2012-09-21 2017-04-19 テクノロヒアス アバンサダス インスピラリア ス.ル.Tecnologias Avanzadas Inspiralia S.L.(25) 心臓修復パッチの新しいスキャフォールド
WO2015027203A1 (en) 2013-08-22 2015-02-26 Arch Biosurgery, Inc. Implantable meshes for controlling the movement of fluids
EP2853256A1 (en) 2013-09-25 2015-04-01 Credentis AG Dental care product for tooth whitening
ES2669548T3 (es) 2013-09-25 2018-05-28 Credentis Ag Producto de cuidado dental para el blanqueamiento de los dientes
DK3116896T3 (en) 2014-03-10 2019-03-18 3 D Matrix Ltd SELF-PREPARING PEPTIME COMPOSITIONS
ES3037364T3 (en) 2014-03-10 2025-10-01 3 D Matrix Ltd Sterilization and filtration of peptide compositions
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
CN104497107B (zh) * 2014-12-08 2017-09-19 重庆医科大学 一种自组装短肽及其在细胞三维培养中的应用
CN104693277B (zh) * 2015-03-26 2018-02-13 罗忠礼 一种自组装短肽及其在细胞三维培养中的应用
CN105148289B (zh) * 2015-09-30 2018-10-09 南京中医药大学 一种两亲性寡聚多肽药物结合物
CN105288653B (zh) * 2015-11-19 2018-10-09 南京中医药大学 一种两亲性寡聚多肽药物结合物
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
EP3248590A1 (en) 2016-05-24 2017-11-29 Credentis AG Personal dental care product for caries treatment
EP3248591A1 (en) 2016-05-24 2017-11-29 Credentis AG Method and product for caries treatment
CN117085140A (zh) 2017-12-15 2023-11-21 立美基股份有限公司 表面活性剂肽纳米结构及在药物递送中的用途
JP7466876B2 (ja) * 2019-02-20 2024-04-15 国立大学法人東京農工大学 自己組織化ペプチド
EP3831360A1 (en) 2019-12-04 2021-06-09 Credentis AG Personal dental care product for preventing demineralisation
US11154470B1 (en) 2020-07-31 2021-10-26 vVardis AG Anti-inflammatory and senolytic dental care product with tooth whitening characteristics
CN114181295B (zh) * 2021-12-15 2023-07-04 湖南大学 一种多肽衍生物及其用途、水凝胶及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955343A (en) * 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
JPH08508511A (ja) * 1993-04-29 1996-09-10 ワシントン・ユニバーシテイー 副行循環の改善への血小板由来成長因子の使用
JPH11506722A (ja) * 1995-06-07 1999-06-15 ベイラー・カレッジ・オブ・メディスン 細胞に核酸を送達するための核酸運搬体
WO2001035932A2 (en) * 1999-11-18 2001-05-25 The Regents Of The University Of Michigan Sustained drug delivery from structural matrices
WO2002062969A2 (en) * 2001-02-06 2002-08-15 Massachusetts Institute Of Technology Cellular reprogramming in peptide hydrogel and uses thereof
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
WO2002076344A1 (en) * 2001-03-23 2002-10-03 Durect Corporation Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
US7179784B2 (en) * 2001-07-10 2007-02-20 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
KR20030043780A (ko) 2001-11-28 2003-06-02 주식회사 바이오폴리메드 생체적합성 비항원성 공중합체와 그 결합체 및 이들의제조방법
US20030139333A1 (en) * 2002-01-18 2003-07-24 Genetix Pharmaceuticals, Inc. Methods and compositions for promoting angiogenesis
US20040242469A1 (en) * 2002-05-13 2004-12-02 Lee Richard T. Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
AU2003274900A1 (en) * 2002-07-15 2004-02-02 Massachusetts Institute Of Technology Cellular reprogramming in peptide hydrogel and uses thereof
JP2004115413A (ja) * 2002-09-25 2004-04-15 Yasuhiko Tabata 冠状動脈狭窄または閉塞治療用徐放性製剤
AU2003297282A1 (en) * 2002-11-14 2004-06-15 Cornell Research Foundation, Inc. Protection of cardiac myocardium
US10100316B2 (en) * 2002-11-21 2018-10-16 Archemix Llc Aptamers comprising CPG motifs
US7641643B2 (en) * 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
WO2005014615A2 (en) * 2003-06-25 2005-02-17 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
CA2572964C (en) * 2004-07-06 2018-03-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof

Similar Documents

Publication Publication Date Title
TWI480069B (zh) 用以改善心肌梗塞之醫藥組成物
JP2023098946A5 (cg-RX-API-DMAC7.html)
TW570805B (en) Water-soluble pharmaceutical composition in an ionic complex
JP2005506340A5 (cg-RX-API-DMAC7.html)
CN1191826C (zh) 药物制剂
JP2011519867A5 (cg-RX-API-DMAC7.html)
CA2452923A1 (en) Peptide-based compounds for targeting integrin receptors
RU99118890A (ru) Водорастворимая фармацевтическая композиция в виде ионного комплекса и ее применение
CN1956735A (zh) 用于增强治疗剂黏膜吸收的递送剂
WO2006073889A3 (en) Sustained delivery of pdgf using self-assembling peptide nanofibers
JP2008513513A5 (cg-RX-API-DMAC7.html)
JP2013535494A5 (cg-RX-API-DMAC7.html)
JP2004527469A5 (cg-RX-API-DMAC7.html)
JP7265303B2 (ja) テリパラチドを含む経口用薬学組成物及びその製造方法
CN1879888B (zh) 透皮给药增强剂及其使用方法
RU2005133665A (ru) Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств
CN112826794B (zh) 一种靶向修复神经血管病变的纳米复合物及其制备与应用
RU2006131553A (ru) Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap
ES2822598T3 (es) Métodos y composiciones para tratar enfermedades y trastornos musculares
RU2011131772A (ru) Генерируемые в результате инсульта усилители ангиогенеза и их применение
ES2296529A1 (es) Composicion farmaceutica con promotores de absorcion.
JP4931306B2 (ja) 骨形成を安全に促進させる医薬複合剤
CN1222310C (zh) 肝实质细胞增殖因子药用制剂
JP2005508875A5 (cg-RX-API-DMAC7.html)
JP5103748B2 (ja) 医薬組成物